-
The lawsuit filed by Attorney General Gentner Drummond will be the first case heard in the newly established Pharmacy Benefit Management Administrative Courts.
-
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription painkiller.
-
Some services shuttered by the closure of Oklahoma County’s Social Services Department will now continue thanks to an allocation from elected officials.
-
The Oklahoma Opioid Abatement Board awarded $11 million in grants to 71 cities, counties, school districts and public trusts, to help them address the state’s opioid crisis during its Tuesday meeting.
-
Oklahoma Governor Kevin Stitt vetoed a bill Friday that would have allowed providers like nurse practitioners to independently prescribe certain drugs.
-
A prescription pill to treat postpartum depression hit the market in December, but most insurers do not yet have a policy on how patients can access it or when they will pay for it.
-
Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara.
-
The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.
-
Bureaucratic hurdles mean just one-in-five people with opioid addiction get access to medication that could help them. The White House says new rules will help.
-
ODMHSAS is launching a new initiative to educate how to safely use, store and dispose of opioids and other prescription meds.